Senators want to know more on why Novo is discontinuing its insulin Levemir
German watchdog approves Novo`s acquisition of Cardior Pharmaceuticals
Metsera, a richly funded biotechnology startup, launched Thursday with a portfolio of weight loss drugs the company claims could eventually compete with market-leading medicines from Novo Nordisk and Eli Lilly.
April 17 (Reuters) - Most doses of Eli Lilly's (LLY.N), opens new tab diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand, the U.S. Food and Drug Administration's website showed on Wednesday.
Green Circle Life Expands Availability of Healthy Weight for Life Program for the SmartFHR™ Platform
Eli Lilly`s nationwide insulin pricing settlement called off
Bagsvrd, Denmark, 15 April 2024 “ On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Bagsvrd, Denmark, 15 April 2024 ” This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated...
EU regulator rules out link between weight-loss drugs and suicidal thoughts
April 11 (Reuters) - German packaging and medical equipment maker Gerresheimer (GXIG.DE), opens new tab expects diabetes and diet drugs to contribute 350 million euros ($376 million) of annual revenue by the 2026/27 financial year, CFO Bernd Metzner told Reuters after the company reported first-quarter results on Thursday.